Developer docs
API playgroundTry for free, no card

Search company profiles

Kalceks

Full company profile

uuid000ze6a

Namestring
Kalceks
Legal namestring
akciju sabiedrība "Kalceks"
Websiteurl
kalceks.lv
Company typeenum
Private
Founded yearint
1920
Descriptiontext

Kalceks is a Latvian pharmaceutical manufacturer founded in 1920 in Riga, specializing in sterile dosage forms and parenteral medicines for the hospital segment. Its portfolio spans cardiovascular, oncology supportive care, anesthetics and analgesics (including myorelaxants), sterile antibiotics, alimentary and metabolism, blood-related, central nervous system, musculoskeletal, ophthalmic, and controlled emergency medicines. Manufacturing is conducted through parent Grindeks Group's facilities in Latvia and Slovakia, supplemented by European contract manufacturers, with strict GMP, ISO 14001, and EU Falsified Medicines Directive compliance (data matrix codes on prescription products since 2019).

The company operates a wholesale-mediated B2B model, selling to pharmaceutical wholesalers that in turn supply hospitals and healthcare institutions across 77 countries, with roughly 60% of exports directed to European markets. Kalceks joined the Grindeks holding group in 2004 and has since pursued active export market development, including direct entry into Germany in 2019 and a long-term distribution partnership with Austria-based EVER Pharma in October 2022 covering five products in cardiology, CNS, and oncology supportive care. The product portfolio was supplemented with seven new generics in 2021 and 42 medicines were reported as under development in 2022, with 16 product registrations secured in Germany and an additional 8 planned.

Revenue is generated through one-time B2B product sales of generic and branded hospital pharmaceuticals; pricing is not publicly disclosed. The company is privately held as a Latvian joint-stock company (akciju sabiedrība "Kalceks"), with no public listing, no disclosed funding rounds, and a headcount of 51-100. Customer-facing engagement is digital-light, relying on a multilingual website, LinkedIn/Facebook presence, and email newsletter, with commercial activity concentrated on direct relationships with pharmaceutical wholesalers and healthcare professionals.

Short descriptiontext

Kalceks is a Latvian pharmaceutical company founded in 1920 that develops and manufactures sterile injectable and hospital medicines — covering cardiovascular, oncology supportive care, anesthetics, antibiotics, and CNS therapies — for distribution through pharmaceutical wholesalers to hospitals across 77 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRiga, Latvia
HQ citystring
Riga
HQ countrystring
Latvia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sterile injectable pharmaceuticals, hospital segment medicines, generic pharmaceutical manufacturing, parenteral dosage forms, controlled hospital medicines
Industry2 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIACAO
Specialty Injectable & Infusion Therapies (Cross-therapeutic)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Hospital Pharmaceuticals (Sterile Injectables and Generic Medicines)
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of generic/hospital pharmaceuticals to wholesalers and healthcare institutions. Products include sterile medicines, controlled medications, anesthetics, myorelaxants, cardiovascular drugs, antibiotics, and oncology products.

kalceks.lv
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Kalceks develops and manufactures generic and specialty pharmaceuticals for the hospital segment, with a focus on sterile dosage forms, parenteral medicines, and injectable solutions. Its portfolio spans cardiovascular, oncology supportive care, anesthetics/analgesics, antibiotics, nervous system, and other therapeutic areas, and is sold to pharmaceutical wholesalers that distribute to hospitals in 77 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Products available in 77 countries worldwide
+1 more record
Product overview1 text field

Kalceks is a pharmaceutical company specializing in hospital segment medications and sterile dosage forms. The product portfolio includes injectable solutions, controlled medicines for resuscitation, CNS, and cardiovascular therapy, organized into therapeutic categories: cardiovascular system, antineoplastics (oncology supportive care), anesthetics and analgesics (including myorelaxants), antibiotics, alimentary tract and metabolism, blood products, nervous system, musculoskeletal system, and eye drops. The company develops and manufactures both generic and proprietary medicines, with production within the Grindeks Group in Latvia and Slovakia, as well as in other contract manufacturing facilities across Europe. Products are exported to 77 countries worldwide with 60% going to European countries.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-10-04
Description

Long-term distribution partnership in Germany covering five products in cardiology, central nervous system, and oncology supportive care therapeutic areas. This partnership nearly doubled the number of Kalceks products marketed in Germany. EVER Pharma is an Austrian-based fully integrated pharmaceutical company founded in 1934, focused on neurology and specialty injectables. Products available in over 70 countries worldwide.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Sandoz (Novartis)
TypeBroad incumbent
Description

World's largest generics manufacturer, with a leading portfolio of hospital sterile injectables across antibiotics, anesthetics, and oncology. Represents the competitive ceiling for hospital injectable generics.

TypeBroad incumbent
Description

Global leader in generic injectable pharmaceuticals, IV drugs, and clinical nutrition for hospitals. Comparable as a major hospital injectables incumbent with overlapping anesthesia, ICU, and oncology supportive care lines.

TypeBroad incumbent
Description

German medical technology and pharmaceutical company offering IV solutions, injectables, and infusion therapy for hospitals. Overlaps with Kalceks in sterile parenteral products and hospital distribution.

TypeRegional player
Description

Slovenian-headquartered generic pharmaceutical manufacturer with strong Central and Eastern European distribution and a growing hospital injectables portfolio. Comparable as a CEE regional generic pharma peer.

TypeEmerging player
Description

India-based generic injectable manufacturer with growing European presence, particularly in hospital antibiotics and sterile injectables. Comparable as a lower-cost emerging player with hospital injectable focus.

TypeDirect peer
Description

Austrian-headquartered specialty injectables and neurology pharmaceutical company with products in over 70 countries. Directly comparable as a hospital-segment injectable generics manufacturer and existing distribution partner of Kalceks.

TypeDirect peer
Description

Specialty generics manufacturer with a strong hospital injectables business across the US, Europe, and MENA. Comparable in therapeutic focus areas including anesthesia, oncology, and cardiovascular injectables.

TypeDirect peer
Description

Switzerland-based sterile injectable generics manufacturer focused on hospital anesthesia, analgesics, and emergency medicines across European and international markets. Closely matches Kalceks' product categories and B2B hospital focus.

TypeRegional player
Description

Polish generic pharmaceutical company with a broad hospital and prescription generics portfolio across Central and Eastern Europe. Comparable as a CEE regional player in similar therapeutic categories.

TypeBroad incumbent
Description

European-focused generic pharmaceutical company with strong hospital injectables portfolio, particularly in Germany and Eastern Europe. Directly competes with Kalceks in Central and Eastern European hospital tenders.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kalceks

Hospital Pharmaceuticals (Sterile Injectables and Generic Medicines)kalceks.lv

Kalceks is a Latvian pharmaceutical company founded in 1920 that develops and manufactures sterile injectable and hospital medicines — covering cardiovascular, oncology supportive care, anesthetics, antibiotics, and CNS therapies — for distribution through pharmaceutical wholesalers to hospitals across 77 countries.

What Kalceks does

Kalceks is a Latvian pharmaceutical manufacturer founded in 1920 in Riga, specializing in sterile dosage forms and parenteral medicines for the hospital segment. Its portfolio spans cardiovascular, oncology supportive care, anesthetics and analgesics (including myorelaxants), sterile antibiotics, alimentary and metabolism, blood-related, central nervous system, musculoskeletal, ophthalmic, and controlled emergency medicines. Manufacturing is conducted through parent Grindeks Group's facilities in Latvia and Slovakia, supplemented by European contract manufacturers, with strict GMP, ISO 14001, and EU Falsified Medicines Directive compliance (data matrix codes on prescription products since 2019).

The company operates a wholesale-mediated B2B model, selling to pharmaceutical wholesalers that in turn supply hospitals and healthcare institutions across 77 countries, with roughly 60% of exports directed to European markets. Kalceks joined the Grindeks holding group in 2004 and has since pursued active export market development, including direct entry into Germany in 2019 and a long-term distribution partnership with Austria-based EVER Pharma in October 2022 covering five products in cardiology, CNS, and oncology supportive care. The product portfolio was supplemented with seven new generics in 2021 and 42 medicines were reported as under development in 2022, with 16 product registrations secured in Germany and an additional 8 planned.

Revenue is generated through one-time B2B product sales of generic and branded hospital pharmaceuticals; pricing is not publicly disclosed. The company is privately held as a Latvian joint-stock company (akciju sabiedrība "Kalceks"), with no public listing, no disclosed funding rounds, and a headcount of 51-100. Customer-facing engagement is digital-light, relying on a multilingual website, LinkedIn/Facebook presence, and email newsletter, with commercial activity concentrated on direct relationships with pharmaceutical wholesalers and healthcare professionals.

Kalceks firmographics

Firmographics
Name
Kalceks
Legal name
akciju sabiedrība "Kalceks"
Website
https://kalceks.lv
Company type
Private
Founded year
1920
Operating status
Operating
Headcount range
11–50 employees
Short description
Kalceks is a Latvian pharmaceutical company founded in 1920 that develops and manufactures sterile injectable and hospital medicines — covering cardiovascular, oncology supportive care, anesthetics, antibiotics, and CNS therapies — for distribution through pharmaceutical wholesalers to hospitals across 77 countries.
Ownership category
akta.pro rank

Kalceks industry classification

Industry
Product category
Hospital Pharmaceuticals (Sterile Injectables and Generic Medicines)
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIACAO
Specialty Injectable & Infusion Therapies (Cross-therapeutic)

Keywords

  • Sterile injectable pharmaceuticals
  • Hospital segment medicines
  • Generic pharmaceutical manufacturing
  • Parenteral dosage forms
  • Controlled hospital medicines

Where Kalceks is headquartered

Location

Headquarters

HQ city
Riga
HQ country
Latvia
HQ region
Europe

Offices1 record

Markets served

Kalceks business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Sale of generic/hospital pharmaceuticals to wholesalers and healthcare institutions. Products include sterile medicines, controlled medications, anesthetics, myorelaxants, cardiovascular drugs, antibiotics, and oncology products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Kalceks product offering

Product offering

Core offering

Kalceks develops and manufactures generic and specialty pharmaceuticals for the hospital segment, with a focus on sterile dosage forms, parenteral medicines, and injectable solutions. Its portfolio spans cardiovascular, oncology supportive care, anesthetics/analgesics, antibiotics, nervous system, and other therapeutic areas, and is sold to pharmaceutical wholesalers that distribute to hospitals in 77 countries.

Product overview

Kalceks is a pharmaceutical company specializing in hospital segment medications and sterile dosage forms. The product portfolio includes injectable solutions, controlled medicines for resuscitation, CNS, and cardiovascular therapy, organized into therapeutic categories: cardiovascular system, antineoplastics (oncology supportive care), anesthetics and analgesics (including myorelaxants), antibiotics, alimentary tract and metabolism, blood products, nervous system, musculoskeletal system, and eye drops. The company develops and manufactures both generic and proprietary medicines, with production within the Grindeks Group in Latvia and Slovakia, as well as in other contract manufacturing facilities across Europe. Products are exported to 77 countries worldwide with 60% going to European countries.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Products available in 77 countries worldwide
  • +1 more outcomes

Companies that use Kalceks

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Kalceks technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Kalceks partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • EVER PharmacoreChannel Partner/ Reseller/ Distributor · 4 October 2022Long-term distribution partnership in Germany covering five products in cardiology, central nervous system, and oncology supportive care therapeutic areas. This partnership nearly doubled the number of Kalceks products marketed in Germany. EVER Pharma is an Austrian-based fully integrated pharmaceutical company founded in 1934, focused on neurology and specialty injectables. Products available in over 70 countries worldwide.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Kalceks competitors and assessment

Company assessment

Broad incumbents

  • Sandoz (Novartis): World's largest generics manufacturer, with a leading portfolio of hospital sterile injectables across antibiotics, anesthetics, and oncology. Represents the competitive ceiling for hospital injectable generics.
  • Fresenius Kabi: Global leader in generic injectable pharmaceuticals, IV drugs, and clinical nutrition for hospitals. Comparable as a major hospital injectables incumbent with overlapping anesthesia, ICU, and oncology supportive care lines.
  • B. Braun: German medical technology and pharmaceutical company offering IV solutions, injectables, and infusion therapy for hospitals. Overlaps with Kalceks in sterile parenteral products and hospital distribution.
  • STADA Arzneimittel: European-focused generic pharmaceutical company with strong hospital injectables portfolio, particularly in Germany and Eastern Europe. Directly competes with Kalceks in Central and Eastern European hospital tenders.

Regional players

  • KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with strong Central and Eastern European distribution and a growing hospital injectables portfolio. Comparable as a CEE regional generic pharma peer.
  • Polpharma: Polish generic pharmaceutical company with a broad hospital and prescription generics portfolio across Central and Eastern Europe. Comparable as a CEE regional player in similar therapeutic categories.

Emerging players

  • Aurobindo Pharma: India-based generic injectable manufacturer with growing European presence, particularly in hospital antibiotics and sterile injectables. Comparable as a lower-cost emerging player with hospital injectable focus.

Direct peers

  • EVER Pharma: Austrian-headquartered specialty injectables and neurology pharmaceutical company with products in over 70 countries. Directly comparable as a hospital-segment injectable generics manufacturer and existing distribution partner of Kalceks.
  • Hikma Pharmaceuticals: Specialty generics manufacturer with a strong hospital injectables business across the US, Europe, and MENA. Comparable in therapeutic focus areas including anesthesia, oncology, and cardiovascular injectables.
  • Sintetica: Switzerland-based sterile injectable generics manufacturer focused on hospital anesthesia, analgesics, and emergency medicines across European and international markets. Closely matches Kalceks' product categories and B2B hospital focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Kalceks social profiles

Digital presence

Kalceks compliance and trust

Trust signal

Compliance4 records

Kalceks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kalceks leadership team

Management profile

Number of profiles

Profiles9 records

Kalceks funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kalceks M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kalceks

What does Kalceks do?

Kalceks develops and manufactures generic and specialty pharmaceuticals for the hospital segment, with a focus on sterile dosage forms, parenteral medicines, and injectable solutions. Its portfolio spans cardiovascular, oncology supportive care, anesthetics/analgesics, antibiotics, nervous system, and other therapeutic areas, and is sold to pharmaceutical wholesalers that distribute to hospitals in 77 countries.

Is Kalceks a public or private company?

Kalceks is a private company. It is classified as corporate owned and is currently operating.

When was Kalceks founded?

Kalceks was founded in 1920. It employs 11 to 50 people.

Where is Kalceks based?

Kalceks is headquartered in Riga, Latvia, in the Europe region.

How does Kalceks make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Kalceks's main competitors?

Broad incumbents on record are Sandoz (Novartis), Fresenius Kabi, B. Braun and STADA Arzneimittel. Regional players are KRKA and Polpharma. Aurobindo Pharma is listed as an emerging player. Direct peers are EVER Pharma, Hikma Pharmaceuticals and Sintetica.

Does Kalceks have an API?

No public API is recorded for Kalceks.

What industry is Kalceks in?

Kalceks's product category is Hospital Pharmaceuticals (Sterile Injectables and Generic Medicines). Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIACAO, Specialty Injectable & Infusion Therapies (Cross-therapeutic). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals